These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36895545)

  • 21. Dosimetric Study of Automatic Brain Metastases Planning in Comparison with Conventional Multi-Isocenter Dynamic Conformal Arc Therapy and Gamma Knife Radiosurgery for Multiple Brain Metastases.
    Mori Y; Kaneda N; Hagiwara M; Ishiguchi T
    Cureus; 2016 Nov; 8(11):e882. PubMed ID: 28003946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robotic Radiosurgical Boost After Whole-Brain Radiotherapy for 12 Brain Metastases: En Bloc Consecutive Irradiation With Comprehensively Optimized Single Plan for Eight Lesions Totaling 118 cc.
    Ohtakara K; Tanahashi K; Yamada T; Tsunoda N; Suzuki K
    Cureus; 2023 Dec; 15(12):e51367. PubMed ID: 38292980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiobiological evaluation considering setup error on single-isocenter irradiation in stereotactic radiosurgery.
    Nakano H; Tanabe S; Sasamoto R; Takizawa T; Utsunomiya S; Sakai M; Nakano T; Ohta A; Kaidu M; Ishikawa H
    J Appl Clin Med Phys; 2021 Jul; 22(7):266-275. PubMed ID: 34151498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant correlation between gross tumor volume (GTV) D98% and local control in multifraction stereotactic radiotherapy (MF-SRT) for unresected brain metastases.
    Dupic G; Brun L; Molnar I; Leyrat B; Chassin V; Moreau J; Dedieu V; Khalil T; Verrelle P; Lapeyre M; Biau J
    Radiother Oncol; 2021 Jan; 154():260-268. PubMed ID: 33245944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac.
    Slagowski JM; Redler G; Malin MJ; Cammin J; Lobb EC; Lee BH; Sethi A; Roeske JC; Flores-Martinez E; Stevens T; Yenice KM; Green O; Mutic S; Aydogan B
    Med Phys; 2020 Nov; 47(11):5455-5466. PubMed ID: 32996591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume.
    Takeda A; Oku Y; Sanuki N; Eriguchi T; Aoki Y; Enomoto T; Kaneko T; Nishimura S; Kunieda E
    J Radiat Res; 2014 Sep; 55(5):988-95. PubMed ID: 24833770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stochastic Predictions of Cell Kill During Stereotactic Ablative Radiation Therapy: Do Hypoxia and Reoxygenation Really Matter?
    Harriss-Phillips WM; Bezak E; Potter A
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1290-7. PubMed ID: 27212197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
    Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
    Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Control Probability After Radiosurgery of Brain Metastases With and Without Retreatment.
    Sharma M; Milano MT; Cummings M; Naqa IE
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):537-544. PubMed ID: 35863671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heuristic knowledge-based planning for single-isocenter stereotactic radiosurgery to multiple brain metastases.
    Ziemer BP; Sanghvi P; Hattangadi-Gluth J; Moore KL
    Med Phys; 2017 Oct; 44(10):5001-5009. PubMed ID: 28731267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas.
    DiBiase SJ; Kwok Y; Yovino S; Arena C; Naqvi S; Temple R; Regine WF; Amin P; Guo C; Chin LS
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1515-9. PubMed ID: 15590183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of increasing gross tumor volume dose with tumor volume reduction and local control in fractionated stereotactic radiosurgery for unresected brain metastases.
    Kanayama N; Ikawa T; Takano K; Arita H; Morimoto M; Hirata T; Ogawa K; Teshima T; Konishi K
    Radiat Oncol; 2024 Jul; 19(1):95. PubMed ID: 39061079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the effect of indirect cell kill in the treatment of multiple brain metastases via single-isocenter/multitarget volumetric modulated arc therapy stereotactic radiosurgery.
    Palmiero AN; Fabian D; Randall ME; Clair W; Pokhrel D
    J Appl Clin Med Phys; 2021 Oct; 22(10):94-103. PubMed ID: 34498359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unified multi-activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS).
    Li S; Miyamoto C; Wang B; Giaddui T; Micaily B; Hollander A; Weiss SE; Weaver M
    Med Phys; 2021 Apr; 48(4):2038-2049. PubMed ID: 33590493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control.
    Kanayama N; Ikawa T; Ohira S; Hirata T; Morimoto M; Ogawa K; Teshima T; Konishi K
    Cancer Med; 2022 Dec; 11(24):4806-4815. PubMed ID: 35535485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
    Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.